Katie Silk

Katie joined AstraZeneca as Director of Global Security Investigations in March 2020 – an interesting time to join the company! Her remit is to ensure that illegal trade, including counterfeiting, illegal diversion, and external threats to AZ products and patient safety are investigated globally. 

Katie joined AstraZeneca in the UK as Director of Global Security Investigations in March 2020 – an interesting time to join the company! Her remit is to ensure that illegal trade, including counterfeiting, illegal diversion, and external threats to AZ products and patient safety are investigated globally.

Katie has 20 years’ of experience in investigations, having worked as an intelligence analyst earlier in her career, before moving to Switzerland and the pharmaceutical industry in 2010. Katie has managed pharma security investigations globally, and also supported Office of Inspector General investigations within a major development aid organisation in Geneva.